Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Psychedelics Today, LLC and Psychedelics Today. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Psychedelics Today, LLC and Psychedelics Today or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

PT562 – Ketamine-Assisted Therapy at Work? The Future of Employee Benefits, with Jessica Tracy

45:51
 
Share
 

Manage episode 448647667 series 2476237
Content provided by Psychedelics Today, LLC and Psychedelics Today. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Psychedelics Today, LLC and Psychedelics Today or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this episode, Joe interviews Jessica Tracy: head of sales & partnerships at Enthea, a company that works with employers, unions, and employee assistance programs to be able to offer ketamine-assisted therapy (and psilocybin where it’s legal) to employees.

She talks about her path to psychedelics and how the shifts in her life led her to want to help others, finding Enthea and using her 15 years of experience in healthcare to make an immediate difference. She explains how the process works for an employee of a company Enthea works with, and the importance of evidence-based medical policy and rigorous screening to make sure people are getting the best intervention possible. One of Enthea’s largest clients is Dr. Bronner’s, who reported incredible improvements after employees used the benefit, with a 65% improvement in depression scores and an 86% improvement in PTSD.

She also discusses:

  • How psychedelics bring awareness to what we need to work on
  • Less-discussed treatment modalities, like electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and stellate ganglion block (SGB)
  • The inefficiency of traditional talk therapy: 50% of people only see really good benefits after 20 sessions
  • The importance of viewing mental health as individualized care: What else can we offer to people who haven’t been helped by traditional methods?
  • The research that she wants to see, like measures in how present or productive people are before and after experiences

and more!

For links, head to the show notes page.

  continue reading

720 episodes

Artwork
iconShare
 
Manage episode 448647667 series 2476237
Content provided by Psychedelics Today, LLC and Psychedelics Today. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Psychedelics Today, LLC and Psychedelics Today or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this episode, Joe interviews Jessica Tracy: head of sales & partnerships at Enthea, a company that works with employers, unions, and employee assistance programs to be able to offer ketamine-assisted therapy (and psilocybin where it’s legal) to employees.

She talks about her path to psychedelics and how the shifts in her life led her to want to help others, finding Enthea and using her 15 years of experience in healthcare to make an immediate difference. She explains how the process works for an employee of a company Enthea works with, and the importance of evidence-based medical policy and rigorous screening to make sure people are getting the best intervention possible. One of Enthea’s largest clients is Dr. Bronner’s, who reported incredible improvements after employees used the benefit, with a 65% improvement in depression scores and an 86% improvement in PTSD.

She also discusses:

  • How psychedelics bring awareness to what we need to work on
  • Less-discussed treatment modalities, like electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and stellate ganglion block (SGB)
  • The inefficiency of traditional talk therapy: 50% of people only see really good benefits after 20 sessions
  • The importance of viewing mental health as individualized care: What else can we offer to people who haven’t been helped by traditional methods?
  • The research that she wants to see, like measures in how present or productive people are before and after experiences

and more!

For links, head to the show notes page.

  continue reading

720 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play